Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gee more BS - but hey the professionals said 40 cents alone a few years back on the previous bread crumb generics. So that would be 20 cents give or take on the existing manufactured generics given the additional dilution since then........however, that 20 cents is not including the 4 Andas in with the FDA currently......let alone the R&D generics going on with SunGen.
But hey i'll not see one iota of proof/evidence/DD that says otherwise.
The MLP space is taking a beating.........and the first and foremost reason is ETP. Let us hope DAPL and ROVER have been cranking on all cylinders. I'd hate to think ETP misses estimated revenue numbers and makes Goldman's downgrade today of ETP and upgrade of ETE look more than wise.
ETP stands to make a lot of money if it can get out of KW's own way.
SunCoke Energy Partners, L.P. Declares Distribution Of $0.5940 Per Unit
https://finance.yahoo.com/news/suncoke-energy-partners-l-p-220000203.html
LISLE, Ill., Oct. 17, 2017 /PRNewswire/ -- Today, the SunCoke Energy Partners, L.P. (SXCP) Board of Directors declared a third quarter 2017 cash distribution of $0.5940 per limited partnership unit, or $2.38 annualized. The third quarter 2017 distribution will be payable on December 1, 2017, to unitholders of record on November 15, 2017.
SunCoke Energy Partners, L.P.
UPCOMING EVENTS
SXCP will host its third quarter 2017 earnings call at 10:00 am ET on October 26, 2017. The conference call will be webcast live and archived for replay in the Investors section of www.suncoke.com. Investors may participate in this call by dialing 1-833-236-5757 in the U.S. or 1-647-689-4185 if outside the U.S., confirmation code 89455983.
ABOUT SUNCOKE ENERGY PARTNERS, L.P.
SunCoke Energy Partners, L.P. (SXCP) is a publicly traded master limited partnership that manufactures high-quality coke used in the blast furnace production of steel and provides export and domestic coal handling services to the coke, coal, steel and power industries. In our cokemaking business, we utilize an innovative heat-recovery technology that captures excess heat for steam or electrical power generation and have long-term, take-or-pay coke contracts that pass through commodity and certain operating costs. Our coal handling terminals have the collective capacity to blend and transload more than 35 million tons of coal each year and are strategically located to reach Gulf Coast, East Coast, Great Lakes and international ports. SXCP's General Partner is a wholly owned subsidiary of SunCoke Energy, Inc. (SXC), which has more than 50 years of cokemaking experience serving the integrated steel industry. To learn more about SunCoke Energy Partners, L.P., visit our website at www.suncoke.com.
Gee and as I predicted at .06 cents - a 10 plus bagger was coming and it did.........guess what another 10 plus bagger is coming from the current PPS. ....again
lol
Lol lol indeed - huh so now I'm to believe the PPS is going back to .06. Now that is funny!!
Gee that is total BS and no proof to the counter will be provided.
Meanwhile Elite continues to file additional Andas quarter in and quarter out.
Total BS. The warning letter isn't a year away from being removed.
It won't take years to get the warning letter removed.
Gee and tell me where the PPS runs to when the warning letter gets removed, when their generic Percocet gets approved, or their Norco.
Yeah sorry I already did. WHOOPSY!!!!
I already posted the 45,000 buy limit order. It should be easy enough to find. Next
Gee that would be the warning letter. WHOOPSY!!!!
Already provided it - 45,000 shares of it. Next
LMFAO; I'm still waiting 20 years later for the .02 cent "SOONS" = lol lol lol
And if I sold for a measly 10 grand I would've made chump change. lol lol lol
I just feel sorry for those who believe the BS. This isn't running to sub penny as I said a 10 plus bagger was coming at .06 cents.
Sorry total BS - I already provided it multiple times.
Gee total BS - as I provided proof several times. Next
Gee and I was told it was time to get out of Elite at .06 cents and then it ran to .97 cents. Next
SunCoke Energy Partners, L.P. (NYSE:SXCP) will be releasing earnings before the market opens on Wednesday, October 18
I could care less how fast light travels as it doesn't change the facts that Elite is highly undervalued here. Nasrat will get the warning letter removed and the PPS will begin to move up.
I'm continuing to buy shares prior its removal.
10 FACTS of LIGHT leading to DOLLARLAND = $$$$$$$$$
1) It's important to keep in mind, and as Nasrat will discuss, our resources are being increasingly focused on our generic and opioid pipeline, and preparing for the launch of the generic products already filed with the FDA, as well as the generics which are licensed currently to Epic that will be coming back to Elite in late 2018, when that license expires.
our business is moving away from this type of revenue stream that is dependent on third parties.
2) the resources which were previously utilized for contract manufacturing were allocated to product development. Instead of making Methadone batches, these resources were used to run batches in products which are under development. In addition, we extended our lab and regulatory personnel to support this greatly increased product development activities.
The level of product development activity is the highest that I've seen since I've been here. And I've been with Elite since 2009.
3) there are three ANDAs already filed and under active review with the FDA. Also several other products in various stages of development that we expect will result in more ANDA filings over the near and mid-terms.
4) SequestOx - We are right now focusing on evaluating the right path forward for us to resolve this issue. Epic is negotiating and engaged with us. We've received several phone calls from them, offering their help and we made the announcement regarding the fat study.
5) Our ER products and pipeline are moving forward - And we are pursuing ER formulations. As a matter of fact, most of the money is in the ER extended release formulation
6) We started our aggressive program of filing one ANDA per quarter in Q3 of 2016. We filed one then and we filed another one in Q4, and a third in Q1 of 2017. We missed Q2 of 2017. We are scheduled to file one in Q3 of this year, so it's going to happen way before the end of this quarter and we are scheduled to file another one in Q4 by December.
7) The FDA has granted us 12-month extension for resubmission. One of my main concerns was if we missed this date by December of this year, which we will - that we will end our PDUFA fee and then we'll have to pay another one. We communicated with the FDA and they give us a 12-month extension. Now we can file any time in 2018 up to and through December 31, 2018 without asking for another extension if needed. And if the results are valid, we can proceed within that timeframe without paying another PDUFA fee.
8) we have many other valuable products that are progressing rapidly right now. At Elite, when we were manufacturing a little more, the number of [entries that I remember on our study] [ph] was about 13. And now, we're up to 50 and growing. And the reason we're growing even though the manufacturing part is not our primary focus and small, is because of all of these projects that are going to lead us within the next couple of years to becoming a seriously viable company. FYI, the total market size of the pipeline products that we are co-developing with SunGen is $6 billion.
9) All Elite needs is about $50 million in profit for our stock to go to dollar land, do the math. For our future growth, Elite pipeline will be the driver. We want to ensure a high rate of revenue growth by aggressively targeting one ANDA filing each quarter. Okay. As I stated earlier, out of the last four quarters we have submitted three ANDAs. We are scheduled to submit one this quarter and one in the quarter after.
10) we have completed the expansion of our manufacturing facility in preparation for our new product approval and launches.
Aright this sounds good ..........now let's see NGL solid earnings on November 3rd!!
Gee that's a real tough one.
Regarding the warning letter, what is the status of the warning letter? Nothing new, the FDA came into Elite. They conducted a full inspection that had several branch. They looked at the previous commitments we made from the previous inspection. They look at the warning letter commitments. They evaluate us for general GMP, and two, three approval inspections.
All these five resulted in [two item 483] [ph] that have nothing to do with warning letter. The inspectors that went through all the attributes of the warning letter, told us that we have met our commitments. We have responded. All the responses are with FDA, and we just await their final decision. I believe it will be favorable. Obviously, the fact that they did not write us up on anything, will tell you it's going to be favorable. But FDA sometimes moves a little slow.
LMMAO!!! So no market for a generic ADT OxyContin.......and there's no generic ADT opioid on the market with FDA label period........and there's no market.
Now that is the funniest thing I've heard here in the last year.
Funny and yet the .02's "SOON" still haven't hit. In another 20 plus years it will still be "SOON".
Now that is funny!
LMAO; sure k as I already provided proof of my last 45,000 shares. Proof has already been provided.
Let's hope their is some tax relief for MLPs coming S80!
Well paying taxes aren't easy on the retail investor that is for sure.
One thing is for certain SXCP's parent company sure isn't worried about it.
Sun Coal & Coke Llc bought 27,605 shares of the firm's stock in a transaction dated Monday, October 16th. The shares were purchased at an average price of $17.61 per share, for a total transaction of $486,124.05.
https://ih.advfn.com/p.php?pid=nmona&article=75871525
Gee now that would true except for the fact that it's not on both accounts. And more relevant I haven't seen any savvy investors who haven't bought at .06 and .07 and .08.
Gee you mean besides those savvy investors who bought at .06, .07 and .08 when it was preached from the rooftops that Elite would never have enough money for a phase 3 trial. LOL LOL
FACT: Nasrat became CEO at .068 = +30%.
Yeah I sure do hate pesky facts = LOL LOL!!!
Total BS - and Elite filings prove it.
Gee sort of like I was guaranteed BK, RS, .02 cent "SOON" and Elite would never have enough money for a phase 3 trial.
I heard the same BS at .06 cents just before it rant to .12 and then to 97.
Yeah I just hate it when a company returns 10% a year.
Gee seems to me I've heard that somewhere before......Oh yeah just before the run to 97.
Lol yeah doesn't change the fact - over 30% since Nasrat became CEO. Next